Human IVD · FIA POCT
FIA POCT test menu
Reagent portfolio for YD-F10, YD-F100, YD-F1600 and YD-F6000. Assays include CRP, PCT, SAA, IL-6, cTnI, NT-proBNP, BNP, D-dimer, AFP, CEA, PSA, HbA1c, TSH, and infectious-disease tests. A listing does not by itself mean the assay is cleared for every instrument or every market.
POCT reagent specifications
YD-F10 uses a dedicated reagent configuration. Confirm the matched reagent, calibration data and registration documents assay by assay. Reagents are supplied in 25-test packs. Reseal the foil pouch after opening and keep the desiccant.
Sample types: WB whole blood, FTB fingertip blood, S serum, P plasma, U urine.
Swipe sideways to see the full table.
| Product | Sample volume | Dilution volume | Sample type | Reaction time | Detection range | Cut-off | Certification |
|---|---|---|---|---|---|---|---|
| CRP | 10 µL WB/FTB5 µL S/P | 75 µL | WB/FTB/S/P | 3 min | 0.5–200 mg/L | hsCRP <1 mg/LCRP <10 mg/L | CE |
| PCT | 100 µL | 75 µL | WB/S/P | 12 min | 0.25–100 ng/mL | <0.5 ng/mL | CE |
| SAA | 10 µL WB/FTB5 µL S/P | 75 µL | WB/FTB/S/P | 3 min | 3–200 mg/L | <10 mg/L | CE |
| CRP/SAA | 10 µL WB/FTB5 µL S/P | 75 µL | WB/FTB/S/P | 3 min | CRP: 0.5–200 mg/LSAA: 3–200 mg/L | CRP <10 mg/LSAA <10 mg/L | CE |
| HBP | 75 µL | 75 µL | P | 12 min | 6–300 ng/mL | <12.0 ng/mL | CE |
| CCP | 20 µL WB10 µL S/P | 75 µL | WB/S/P | 10 min | 5–640 RU/mL | Refer to user manual | CE |
| RF/ASO/CRP | 10 µL | 75 µL | S | 10 min | RF: 10–120 IU/mLASO: 30–600 IU/mLCRP: 1–100 mg/L | RF <20 IU/mLASO <200 IU/mLCRP <10 mg/L | CE |
| RF | 10 µL | 75 µL | WB/S/P | 10 min | RF: 10–120 IU/mL | RF <20 IU/mL | CE |
| ASO | 10 µL | 75 µL | WB/S/P | 10 min | ASO: 30–600 IU/mL | ASO <200 IU/mL | CE |
| IL-6 | 75 µL | 75 µL | WB/S/P | 12 min | 3–4000 pg/mL | <7 pg/mL | CE |
| PCT/IL-6 | 75 µL | 75 µL | WB/S/P | 12 min | PCT: 0.06–100 ng/mLIL-6: 3.5–4000 pg/mL | PCT <0.1 ng/mLIL-6 <7 pg/mL | CE |
| cTnI | 75 µL | 75 µL | WB/S/P | 12 min | 0.05–50 ng/mL | <0.1 ng/mL | CE |
| CK-MB | 75 µL | 75 µL | WB/S/P | 12 min | 0.3–100 ng/mL | <6 ng/mL | CE |
| Myo | 75 µL | 75 µL | WB/S/P | 12 min | 5–1000 ng/mL | <100 ng/mL | CE |
| D-D | 100 µL WB75 µL P | 75 µL | WB/P | 5 min | 0.05–10 mg/L | <0.5 mg/L | CE |
| NT-proBNP | 150 µL WB100 µL S/P | 75 µL | WB/S/P | 12 min | 100–45000 pg/mL | <75 years: <300 pg/mL≥75 years: <450 pg/mL | CE |
| H-FABP | 75 µL | 75 µL | S/P | 12 min | 2–150 ng/mL | <7 ng/mL | CE |
| cTnI/CK-MB/Myo | 75 µL | 75 µL | WB/S/P | 15 min | cTnI: 0.05–50 ng/mLCK-MB: 1–100 ng/mLMyo: 5–600 ng/mL | cTnI: <0.1 ng/mLCK-MB: <6 ng/mLMyo: <100 ng/mL | CE |
| cTnI/NT-proBNP/D-D | 100 µL | 100 µL | WB/P | 15 min | cTnI: 0.1–50 ng/mLNT-proBNP: 100–45000 pg/mLD-D: 0.05–10 mg/L | Refer to user manual | CE |
| ST2 | 75 µL | 75 µL | WB/S/P | 12 min | 3–200 ng/mL | ≤35 ng/mL | CE |
| NT-proBNP/ST2 | 75 µL | 75 µL | WB/S/P | 12 min | NT-proBNP: 100–45000 pg/mLST2: 3–200 ng/mL | Refer to user manual | CE |
| Lp-PLA2 | 75 µL | 75 µL | WB/S/P | 5 min | 10–800 ng/mL | <175 ng/mL | CE |
| cTnT | 75 µL | 75 µL | WB/S/P | 12 min | 0.03–10 ng/mL | <0.1 ng/mL | CE |
| BNP | 75 µL | 75 µL | WB/P | 12 min | 5–5000 pg/mL | <100 pg/mL | CE |
| hs-cTnI | 75 µL | 75 µL | WB/S/P | 10 min | 12.2–50000 ng/L | Male: <45 ng/LFemale: <35 ng/L | CE |
| CPP | 75 µL | 75 µL | WB/S/P | 12 min | 31.25–2000 pg/mL | <70 pg/mL | CE |
| GDF-15 | 75 µL | 75 µL | WB/S/P | 12 min | 400–20000 pg/mL | Refer to user manual | CE |
| AFP | 75 µL | 75 µL | S/P | 12 min | 5–1000 ng/mL | <20 ng/mL | CE |
| t-PSA | 100 µL | 100 µL | WB/S/P | 12 min | 2–100 ng/mL | <4 ng/mL | CE |
| CEA | 75 µL | 75 µL | S/P | 12 min | 2.5–600 ng/mL | <5 ng/mL | CE |
| PG I | 75 µL | 75 µL | S | 12 min | 10–300 ng/mL | 70–200 ng/mL | CE |
| PG II | 75 µL | 75 µL | S | 12 min | 5–100 ng/mL | <15 ng/mL | CE |
| FOB | 6 fresh fecal positions | 2–3 drops(70–100 µL) | Fecal | 10 min | 50–1200 ng/mL | <100 ng/mL (20 µg/g feces) | CE |
| S100β | 100 µL | 100 µL | WB/S/P | 15 min | 0.05–10 ng/mL | <0.2 ng/mL | CE |
| VEGF | 100 µL | 100 µL | WB/S/P | 15 min | 50–3200 pg/mL | <160 pg/mL | CE |
| G-17 | 75 µL | 75 µL | WB/S/P | 12 min | 0.5–320 pmol/L | 1–7 pmol/L | CE |
| PGI+PGII | 75 µL | 75 µL | S | 12 min | PGI: 10–300 ng/mLPGII: 5–100 ng/mL | PGI: 70–200 ng/mLPGII: <15 ng/mL | CE |
| CA125 | 75 µL | 75 µL | WB/S/P | 12 min | 10–2000 U/mL | <35 U/mL | CE |
| CA15-3 | 10 µL | 75 µL | WB/S/P | 12 min | 5–300 U/mL | <26.2 U/mL | CE |
| CA19-9 | 75 µL | 75 µL | WB/S/P | 12 min | 8–1000 U/mL | <27 U/mL | CE |
| Cys C | 10 µL | 75 µL | S/P | 10 min | 0.2–10 mg/L | <1.2 mg/L | CE |
| β2-MG | 5 µL | 75 µL | S/P | 10 min | 0.1–18 mg/L | 1–3 mg/L | CE |
| NGAL | 10 µL | 75 µL | S | 10 min | 10–3000 ng/mL | <150 ng/mL | CE |
| MAU | 5 µL | 75 µL | U | 5 min | 2–300 mg/L | <20 mg/L | CE |
| HbA1c | 5 µL | 75 µL | WB | 6 min | 4.0–15.0% | 4–6% | CE |
| ADPN | 10 µL | 75 µL | WB/S/P | 10 min | 2.0–40 µg/mL | 2.6–12.5 µg/mL | CE |
| MP IgM | 10 µL S/P20 µL WB | 75 µL | WB/S/P | 10 min | 5–160 RU/mL | Refer to user manual | CE |
| MP IgG | 10 µL S/P20 µL WB | 75 µL | WB/S/P | 10 min | 5–160 RU/mL | Refer to user manual | CE |
| Cpn IgM | 10 µL S/P20 µL WB | 75 µL | WB/S/P | 10 min | 5–160 RU/mL | Refer to user manual | |
| SARS-CoV-2 | 75 µL | 100 µL | WB/S/P | 15 min | Qualitative | Refer to user manual | CE |
| Cpn IgG | 10 µL S/P20 µL WB | 75 µL | WB/S/P | 10 min | 5–160 RU/mL | Refer to user manual | |
| MP | — | 3–4 drops(100 µL) | Oropharyngeal swab | 15 min | Qualitative | Negative: result <1.0Positive: result ≥1.0 | CE |
| Cpn | — | 3–4 drops(100 µL) | Oropharyngeal swab | 15 min | Qualitative | Negative: result <1.0Positive: result ≥1.0 | |
| Adv | — | 3–4 drops(100 µL) | Nasopharyngeal swab | 10 min | Qualitative | Negative: result <1.0Positive: result ≥1.0 | CE |
| RSV | — | 3–4 drops(100 µL) | Nasopharyngeal swab | 10 min | Qualitative | Negative: result <1.0Positive: result ≥1.0 | CE |
| Strep A | — | 3–4 drops(100 µL) | Oropharyngeal swab | 10 min | Qualitative | Negative: result <1.0Positive: result ≥1.0 | CE |
| Influenza A+B | — | 3–4 drops(100 µL) | Nasopharyngeal swab | 10 min | Qualitative | Negative: result <1.0Positive: result ≥1.0 | CE |
| H. pylori Ab | 75 µL | 100 µL | WB/S/P | 15 min | Urease: 10–320 RU/mLVacA: 5–80 RU/mLCagA: 7.5–120 RU/mL | Urease: <20.0 RU/mLVacA: <10.0 RU/mLCagA: <15.0 RU/mL | CE |
| Dengue NS1 | 75 µL | 75 µL | WB/S/P | 12 min | Qualitative | Negative: result <1.0Positive: result ≥1.0 | CE |
| Dengue IgM/IgG | 75 µL | 75 µL | WB/S/P | 12 min | Qualitative | Refer to user manual | CE |
| HBsAb | 100 µL | 100 µL | WB/S/P | 15 min | 10 mIU/mL–1000 mIU/mL | <10 mIU/mL | |
| Total β-HCG | 100 µL | 100 µL | S | 15 min | 25–10000 mIU/mL | <25 mIU/mL | CE |
| T3 | 75 µL | 75 µL | S | 15 minMix thoroughly for 5 min | 0.61–9.22 nmol/L | 1.23–3.07 nmol/L | CE |
| T4 | 75 µL | 75 µL | S | 15 minMix thoroughly for 5 min | 12.87–310 nmol/L | 66–181 nmol/L | CE |
| TSH | 75 µL | 75 µL | S | 15 min | 0.1–100 mIU/L | 0.3–4.2 mIU/L | CE |
| FT4 | 75 µL | 75 µL | S | 15 minMix thoroughly for 1 min | 6.0–120 pmol/L | 12–22 pmol/L | CE |
| FT3 | 75 µL | 75 µL | S | 15 minMix thoroughly for 1 min | 2.0–50 pmol/L | 3.1–7.0 pmol/L | CE |
| FSH | 75 µL | 75 µL | WB/S/P | 15 min | 1–150 mIU/mL | Refer to user manual | CE |
| LH | 75 µL | 75 µL | WB/S/P | 15 min | 1–150 mIU/mL | Refer to user manual | CE |
| HCG | 60 µL | 75 µL | S | 15 min | 10–200000 mIU/mL | <10 mIU/mL | CE |
| AMH | 75 µL | 75 µL | WB/S/P | 12 min | 0.1–16 ng/mL | Refer to user manual | CE |
| Prog | 75 µL | 75 µL | WB/S/P | 15 min | 1–60 ng/mL | Refer to user manual | CE |
| Testo | 75 µL | 75 µL | WB/S/P | 15 min | 0.1–15 ng/mL | Adult male: 1.5–10 ng/mLAdult female: 0.1–0.6 ng/mL | CE |
| IGF-1 | 10 µL | 75 µL | WB/S/P | 15 min | 20.0–1600.0 ng/mL | Refer to user manual | |
| IGFBP-3 | 10 µL | 75 µL | WB/S/P | 15 min | 0.30–16.00 µg/mL | Refer to user manual | |
| E2 | 75 µL | 75 µL | WB/S/P | 15 min | 20–3000 pg/mL | Refer to user manual | CE |
| PRL | 75 µL | 75 µL | WB/S/P | 15 min | 1–200 ng/mL | Refer to user manual | CE |
| 25-OH-D | 10 µL | 100 µL | WB/S/P | 15 min | 5–70 ng/mL | ≥30 ng/mL | CE |
| Ferr | 10 µL | 100 µL | WB/S/P | 15 min | 5–500 ng/mL | Male: 30–400 ng/mLFemale: 15–150 ng/mL | CE |
| FA | 10 µL | 100 µL | WB/S/P | 15 min | 1.5–20 ng/mL | 4.9–19.1 ng/mL | CE |
| VB12 | 100 µL | 100 µL | WB/S/P | 15 min | 150–1500 pg/mL | 240–800 pg/mL | CE |
| HB+TF | 6 fresh fecal positions | 2–3 drops | Fecal | 15 min | HB: 50–1200 ng/mLTF: 20–1200 ng/mL | HB: <100 ng/mLTF: <40 ng/mL (8 µg/g feces) | CE |
| tIgE | 10 µL | 75 µL | WB/S/P | 10 min | 2–1000 IU/mL | Refer to user manual |
83 assays. Where the source table leaves certification blank, this page leaves it blank.